Christopher Patterson

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. doi General risk factors for dementia: a systematic evidence review
    Christopher Patterson
    Division of Geriatric Medicine, Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
    Alzheimers Dement 3:341-7. 2007
  2. doi Primary prevention of dementia
    Christopher Patterson
    Division of Geriatric Medicine, Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
    Alzheimers Dement 3:348-54. 2007
  3. pmc A randomized trial of mail vs. telephone invitation to a community-based cardiovascular health awareness program for older family practice patients [ISRCTN61739603]
    Tina Karwalajtys
    Department of Family Medicine, McMaster University, Hamilton, Canada
    BMC Fam Pract 6:35. 2005
  4. pmc Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease
    Christopher Patterson
    Division of Geriatric Medicine, McMaster University, Hamilton, Ont
    CMAJ 178:548-56. 2008
  5. pmc Predictors of family caregiver ratings of patient quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study
    Gary Naglie
    Division of General Internal Medicine, University Health Network, Toronto, Ontario, Canada
    Am J Geriatr Psychiatry 19:891-901. 2011
  6. doi Ascertainment of chronic diseases in the Canadian longitudinal study on aging (CLSA), systematic review
    Parminder S Raina
    McMaster Evidence Based Practice Center, McMaster University, Canada
    Can J Aging 28:275-85. 2009
  7. doi The Canadian longitudinal study on aging (CLSA)
    Parminder S Raina
    McMaster Evidence Based Practice Center, McMaster University, Canada
    Can J Aging 28:221-9. 2009
  8. pmc Predictors of patient self-ratings of quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study
    Gary Naglie
    Division of General Internal Medicine GN, MK, University Health Network, Toronto, Ontario, Canada
    Am J Geriatr Psychiatry 19:881-90. 2011
  9. doi Validating chronic disease ascertainment algorithms for use in the Canadian longitudinal study on aging
    Mark Oremus
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada
    Can J Aging 32:232-9. 2013
  10. doi Minding the gap: Prioritization of care issues among nurse practitioners, family physicians and geriatricians when caring for the elderly
    Ainsley Moore
    Department of Family Medicine, McMaster University, Ontario, Canada and
    J Interprof Care 29:401-3. 2015

Collaborators

Detail Information

Publications29

  1. doi General risk factors for dementia: a systematic evidence review
    Christopher Patterson
    Division of Geriatric Medicine, Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
    Alzheimers Dement 3:341-7. 2007
    ..This review identifies and quantifies general (ie, nongenetic) risk factors for all-cause dementia, Alzheimer's disease, and vascular dementia specifically...
  2. doi Primary prevention of dementia
    Christopher Patterson
    Division of Geriatric Medicine, Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
    Alzheimers Dement 3:348-54. 2007
    ..The purpose of this article is to recommend strategies to practicing physicians for the prevention of dementia in people without preexisting cognitive deficits...
  3. pmc A randomized trial of mail vs. telephone invitation to a community-based cardiovascular health awareness program for older family practice patients [ISRCTN61739603]
    Tina Karwalajtys
    Department of Family Medicine, McMaster University, Hamilton, Canada
    BMC Fam Pract 6:35. 2005
    ....
  4. pmc Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease
    Christopher Patterson
    Division of Geriatric Medicine, McMaster University, Hamilton, Ont
    CMAJ 178:548-56. 2008
    ....
  5. pmc Predictors of family caregiver ratings of patient quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study
    Gary Naglie
    Division of General Internal Medicine, University Health Network, Toronto, Ontario, Canada
    Am J Geriatr Psychiatry 19:891-901. 2011
    ..To assess whether the core symptoms of Alzheimer disease (AD) and caregiver factors consistently predict family caregiver ratings of patient quality of life (QOL) as assessed by a variety of QOL measures in a large national sample...
  6. doi Ascertainment of chronic diseases in the Canadian longitudinal study on aging (CLSA), systematic review
    Parminder S Raina
    McMaster Evidence Based Practice Center, McMaster University, Canada
    Can J Aging 28:275-85. 2009
    ..g., blood pressure) as well as laboratory measures (e.g., glucose). This pilot study identified the tools necessary to develop disease ascertainment algorithms...
  7. doi The Canadian longitudinal study on aging (CLSA)
    Parminder S Raina
    McMaster Evidence Based Practice Center, McMaster University, Canada
    Can J Aging 28:221-9. 2009
    ..The CLSA will become a rich data source for the study of the complex interrelationship among the biological, physical, psychosocial, and societal factors that affect healthy aging...
  8. pmc Predictors of patient self-ratings of quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study
    Gary Naglie
    Division of General Internal Medicine GN, MK, University Health Network, Toronto, Ontario, Canada
    Am J Geriatr Psychiatry 19:881-90. 2011
    ..To assess whether the core symptoms of Alzheimer disease (AD) consistently predict patient self-rated quality of life (QOL) as assessed by a variety of QOL measures in a large national sample of AD patients...
  9. doi Validating chronic disease ascertainment algorithms for use in the Canadian longitudinal study on aging
    Mark Oremus
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada
    Can J Aging 32:232-9. 2013
    ..Most estimated sensitivities and specificities were 80 per cent or more, indicating that the seven algorithms correctly identified individuals with the target disease...
  10. doi Minding the gap: Prioritization of care issues among nurse practitioners, family physicians and geriatricians when caring for the elderly
    Ainsley Moore
    Department of Family Medicine, McMaster University, Ontario, Canada and
    J Interprof Care 29:401-3. 2015
    ..Our findings identify a need for a more clearly defined role for the geriatrician as syndrome-educator and implies further need for collaborative approaches to caring for seniors that values different professional's expertise. ..
  11. pmc Vitamin D, cognition, and dementia: a systematic review and meta-analysis
    Cynthia Balion
    Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada
    Neurology 79:1397-405. 2012
    ..To examine the association between cognitive function and dementia with vitamin D concentration in adults...
  12. doi Functional disability and social participation restriction associated with chronic conditions in middle-aged and older adults
    Lauren E Griffith
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    J Epidemiol Community Health . 2016
    ..We examine the population impact on functional disability and social participation of physical and mental chronic conditions individually and in combination...
  13. pmc Patterns of health service use in community living older adults with dementia and comorbid conditions: a population-based retrospective cohort study in Ontario, Canada
    Lauren E Griffith
    Department of Clinical Epidemiology and Biostatistics, McMaster University, McMaster Innovation Park, 175 Longwood Road South, Hamilton, ON, L8P 0A1, Canada
    BMC Geriatr 16:177. 2016
    ....
  14. pmc Interprofessional and integrated care of the elderly in a family health team
    Ainsley Moore
    Department of Family Medicine, McMaster University, Hamilton, ON
    Can Fam Physician 58:e436-41. 2012
    ..Family physicians provide most of the care for the frail elderly population, but many challenges and barriers can lead to difficulties with fragmented, ineffective, and inefficient services...
  15. pmc Care recipients' physical frailty is independently associated with subjective burden in informal caregivers in the community setting: a cross-sectional study
    Thom J Ringer
    GERAS Centre, Hamilton Health Sciences St Peter s Hospital Site, 88 Maplewood Avenue, Hamilton, ON, L8M 1W9, Canada
    BMC Geriatr 16:186. 2016
    ..This cross-sectional study evaluated the relationship between physical frailty of community-dwelling older adults attending an outpatient geriatric clinic and the subjective burden reported by their informal caregivers...
  16. ncbi Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline
    Parminder Raina
    McMaster University, Hamilton, Ontario, Canada
    Ann Intern Med 148:379-97. 2008
    ..The effectiveness of the 5 U.S. Food and Drug Administration-approved pharmacologic therapies for dementias in achieving clinically relevant improvements is unclear...
  17. pmc Brain type carnosinase in dementia: a pilot study
    Cynthia M Balion
    Department of Laboratory Medicine, Hamilton Health Sciences, Hamilton, Ontario, Canada
    BMC Neurol 7:38. 2007
    ..Carnosinase is a dipeptidase found almost exclusively in brain and serum. Carnosinase and its substrate carnosine have been linked to neuropathophysiological processes...
  18. ncbi Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging
    Giovanni Ravaglia
    Department of Internal Medicine, Cardioangiology, and Hepatology, University Hospital S Orsola Malpighi, Via Massarenti, 9, 40138 Bologna, Italy
    Neurobiol Aging 28:1810-20. 2007
    ..91; 95%CI, 1.02-3.56) but not VaD risk. Blood inflammatory markers are associated with increased VaD risk but do not predict AD, which seems selectively associated with hyperhomocysteinemia...
  19. ncbi Comparison studies of cholinesterase inhibitors for Alzheimer's disease
    David B Hogan
    Division of Geriatric Medicine, University of Calgary, Calgary, Alberta, Canada
    Lancet Neurol 3:622-6. 2004
    ..Between 27% and 55% of CONSORT items per study were rated as inadequately reported. The methodological limitations of these studies reduce our confidence in the validity of the conclusions drawn in the published reports...
  20. ncbi Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study
    John Yarnell
    Department of Epidemiology and Public Health, Queen s University of Belfast, UK
    Eur Heart J 26:332-42; discussion 317-8. 2005
    ..We therefore measured thrombotic and inflammatory markers in a substudy of the WHO MONICA project and correlated these with CHD event rates...
  21. ncbi Translating evidence into practice: the case of dementia guidelines in specialized geriatric services
    David L Lewis
    Regional Geriatrics Program Central, 88 Maplewood Avenue, Hamilton, ON, L8M 1W9, Canada
    Can J Aging 24:251-60. 2005
    ..Outcomes of the process included a resource manual, a network of practitioners, and action recommendations based upon survey data. An early follow-up evaluation showed increased adoption of guidelines...
  22. ncbi Metabolic Syndrome: prevalence and prediction of mortality in elderly individuals
    Giovanni Ravaglia
    Department of Internal Medicine, Cardioangiology, and Hepatology, University of Bologna, Via Massarenti, 9 40138 Bologna, Italy
    Diabetes Care 29:2471-6. 2006
    ....
  23. ncbi Apolipoprotein E e4 allele affects risk of hyperhomocysteinemia in the elderly
    Giovanni Ravaglia
    Department of Internal Medicine, Cardioangiology, and Hepatology, University Hospital S Orsola Malpighi, Bologna, Italy
    Am J Clin Nutr 84:1473-80. 2006
    ..Homocysteine, another risk factor for vascular disease and dementia, also binds to VLDL in blood. However, the association between APOE4 and hyperhomocysteinemia has never been thoroughly investigated...
  24. ncbi Endogenous sex hormones as risk factors for dementia in elderly men and women
    Giovanni Ravaglia
    Department of Internal Medicine, Cardioangiology, and Hepatology, University Hospital S Orsola, Malpighi, Via Massarenti, 9 40138 Bologna, Italy
    J Gerontol A Biol Sci Med Sci 62:1035-41. 2007
    ..The associations of endogenous sex hormones with risk of dementia in the elderly population are not well known...
  25. doi Development of an easy prognostic score for frailty outcomes in the aged
    Giovanni Ravaglia
    Department of Internal Medicine, Cardioangiology and Hepatology, University of Bologna, Italy
    Age Ageing 37:161-6. 2008
    ..identification of frailty is recommended in geriatric practice. However, there is a lack of frailty scores combining easy-to-collect predictors from multiple domains...
  26. ncbi Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort
    Giovanni Ravaglia
    Department of Internal Medicine, Cardioangiology, and Hepatology, University Hospital Sant Orsola Malpighi, University of Bologna, Bologna, Italy
    Am J Clin Nutr 87:1306-13. 2008
    ..The most abundant and most investigated form of vitamin E in humans is alpha-tocopherol, but other antioxidant tocopherols (beta, gamma, and delta) exist in nature...
  27. ncbi Progress in clinical neurosciences: Treatment of Alzheimer's disease and other dementias--review and comparison of the cholinesterase inhibitors
    David B Hogan
    Department of Medicine, University of Calgary, Calgary Alberta, Canada
    Can J Neurol Sci 29:306-14. 2002
    ..Acceptance of the cholinergic hypothesis led to a search for medications which could enhance central cholinergic activity in this condition. There are now three cholinesterase inhibitors available for the treatment of AD in Canada...